Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:3457-3464
Published online before print June 20, 2005, doi: 10.1161/CIRCULATIONAHA.104.523563
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
111/25/3457    most recent
CIRCULATIONAHA.104.523563v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, S.
Right arrow Articles by Krieger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, S.
Right arrow Articles by Krieger, M.
Related Collections
Right arrow Animal models of human disease
Right arrow Pathophysiology
Right arrow Genetically altered mice
Right arrow Acute myocardial infarction
Right arrow Lipid and lipoprotein metabolism
Right arrowRelated Article

(Circulation. 2005;111:3457-3464.)
© 2005 American Heart Association, Inc.


Vascular Medicine

Diet-Induced Occlusive Coronary Atherosclerosis, Myocardial Infarction, Cardiac Dysfunction, and Premature Death in Scavenger Receptor Class B Type I-Deficient, Hypomorphic Apolipoprotein ER61 Mice

Songwen Zhang, PhD; Michael H. Picard, MD; Eliza Vasile, PhD; Yu Zhu, MD; Robert L. Raffai, PhD; Karl H. Weisgraber, PhD; Monty Krieger, PhD

From the Department of Biology, Massachusetts Institute of Technology, Cambridge (S.Z., E.V., Y.Z., M.K.); Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston (M.H.P.); Division of Vascular Surgery, Department of Surgery, University of California, San Francisco and San Francisco Veterans Administration Medical Research Center (R.L.R.); and Department of Pathology and Cardiovascular Research Institute, Gladstone Institutes of Cardiovascular Disease and Neurological Disease, University of California, San Francisco (K.H.W.).

Correspondence to Monty Krieger, Biology Department, Room 68-483, Massachusetts Institute of Technology, Cambridge, MA 02139. E-mail krieger{at}mit.edu

Received November 23, 2004; revision received February 4, 2005; accepted February 16, 2005.

Background— Normal chow (low fat)–fed mice deficient in both the HDL receptor SR-BI and apolipoprotein E (SR-BI/apoE dKO) provide a distinctive model of coronary heart disease (CHD). They exhibit early-onset hypercholesterolemia characterized by unesterified cholesterol-rich abnormal lipoproteins (lamellar/vesicular and stacked discoidal particles), occlusive coronary atherosclerosis, spontaneous myocardial infarction, cardiac dysfunction, and premature death ({approx}6 weeks of age). Mice in which similar features of CHD could be induced with a lipid-rich diet would represent a powerful tool to study CHD.

Methods and Results— To generate a diet-inducible model of CHD, we bred SR-BI-deficient (SR-BI KO) mice with hypomorphic apolipoprotein E mice (ApoeR61h/h) that express reduced levels of an apoE4-like murine apoE isoform and exhibit diet-induced hypercholesterolemia. When fed a normal chow diet, SR-BI KO/ApoeR61h/h mice did not exhibit early-onset atherosclerosis or CHD; the low expression level of the apoE4-like murine apoE was atheroprotective and cardioprotective. However, when fed an atherogenic diet rich in fat, cholesterol, and cholate, they rapidly developed hypercholesterolemia, atherosclerosis, and CHD, a response strikingly similar to that of SR-BI/apoE dKO mice fed a chow diet, and they died 32±6 days (50% mortality) after initiation of the high-fat feeding.

Conclusions— The SR-BI KO/ApoeR61h/h mouse is a new model of diet-induced occlusive coronary atherosclerosis and CHD (myocardial infarction, cardiac dysfunction and premature death), allowing control of the age of onset, duration, severity, and possibly regression of disease. Thus, SR-BI KO/ApoeR61h/h mice have the potential to contribute to our understanding of CHD and its prevention and treatment.


Key Words: apolipoproteins • atherosclerosis • diet • myocardial infarction • receptors


Related Article:

Interplay Between Apolipoprotein E and Scavenger Receptor Class B Type I Controls Coronary Atherosclerosis and Lifespan in the Mouse
Sergio Fazio and MacRae F. Linton
Circulation 2005 111: 3349-3351. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Tomiyama-Hanayama, H. Rakugi, M. Kohara, T. Mima, Y. Adachi, M. Ohishi, T. Katsuya, Y. Hoshida, K. Aozasa, T. Ogihara, et al.
Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice
Am J Physiol Renal Physiol, September 1, 2009; 297(3): F679 - F684.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. P. Hans, M. Zerfaoui, A. S. Naura, D. Troxclair, J. P. Strong, K. Matrougui, and A. H. Boulares
Thieno[2,3-c]Isoquinolin-5-one, a Potent Poly(ADP-Ribose) Polymerase Inhibitor, Promotes Atherosclerotic Plaque Regression in High-Fat Diet-Fed Apolipoprotein E-Deficient Mice: Effects on Inflammatory Markers and Lipid Content
J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 150 - 158.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. Hsueh, E. D. Abel, J. L. Breslow, N. Maeda, R. C. Davis, E. A. Fisher, H. Dansky, D. A. McClain, R. McIndoe, M. K. Wassef, et al.
Recipes for Creating Animal Models of Diabetic Cardiovascular Disease
Circ. Res., May 25, 2007; 100(10): 1415 - 1427.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. G. Yancey, W. G. Jerome, H. Yu, E. E. Griffin, B. E. Cox, V. R. Babaev, S. Fazio, and M. F. Linton
Severely altered cholesterol homeostasis in macrophages lacking apoE and SR-BI
J. Lipid Res., May 1, 2007; 48(5): 1140 - 1149.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. M. Schwartz, Z. S. Galis, M. E. Rosenfeld, and E. Falk
Plaque Rupture in Humans and Mice
Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 705 - 713.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
E. J. Topol, J. Smith, E. F. Plow, and Q. K. Wang
Genetic susceptibility to myocardial infarction and coronary artery disease
Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R117 - R123.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Yesilaltay, O. Kocher, R. Pal, A. Leiva, V. Quinones, A. Rigotti, and M. Krieger
PDZK1 Is Required for Maintaining Hepatic Scavenger Receptor, Class B, Type I (SR-BI) Steady State Levels but Not Its Surface Localization or Function
J. Biol. Chem., September 29, 2006; 281(39): 28975 - 28980.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. J. Moore and M. W. Freeman
Scavenger Receptors in Atherosclerosis: Beyond Lipid Uptake
Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1702 - 1711.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Yesilaltay, M. G. Morales, L. Amigo, S. Zanlungo, A. Rigotti, S. L. Karackattu, M. H. Donahee, K. F. Kozarsky, and M. Krieger
Effects of Hepatic Expression of the High-Density Lipoprotein Receptor SR-BI on Lipoprotein Metabolism and Female Fertility
Endocrinology, April 1, 2006; 147(4): 1577 - 1588.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. L. Karackattu, B. Trigatti, and M. Krieger
Hepatic Lipase Deficiency Delays Atherosclerosis, Myocardial Infarction, and Cardiac Dysfunction and Extends Lifespan in SR-BI/Apolipoprotein E Double Knockout Mice
Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 548 - 554.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Yu, W. Zhang, P. G. Yancey, M. J. Koury, Y. Zhang, S. Fazio, and M. F. Linton
Macrophage Apolipoprotein E Reduces Atherosclerosis and Prevents Premature Death in Apolipoprotein E and Scavenger Receptor-Class BI Double-Knockout Mice
Arterioscler Thromb Vasc Biol, January 1, 2006; 26(1): 150 - 156.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Fazio and M. F. Linton
Interplay Between Apolipoprotein E and Scavenger Receptor Class B Type I Controls Coronary Atherosclerosis and Lifespan in the Mouse
Circulation, June 28, 2005; 111(25): 3349 - 3351.
[Full Text] [PDF]